Medium-dosage SARS-CoV-2 vaccine — Competitive Intelligence Brief

Medium-dosage SARS-CoV-2 vaccine (Medium-dosage SARS-CoV-2 vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: inactivated viral vaccine. Area: Immunology.

marketed inactivated viral vaccine Immunology Biologic

Target snapshot

Medium-dosage SARS-CoV-2 vaccine (Medium-dosage SARS-CoV-2 vaccine) — Sinovac Biotech Co., Ltd. This inactivated SARS-CoV-2 vaccine stimulates the immune system to produce antibodies and cellular immunity against the virus by presenting inactivated viral particles.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Medium-dosage SARS-CoV-2 vaccine TARGET	Medium-dosage SARS-CoV-2 vaccine	Sinovac Biotech Co., Ltd	marketed	inactivated viral vaccine
EV71 Vaccine only	EV71 Vaccine only	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Enterovirus 71 (EV71) viral antigens
sIPV batch 3	sIPV batch 3	Institute of Medical Biology, Chinese Academy of Medical Sciences	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3
Vaqta Injectable Product	Vaqta Injectable Product	National Taiwan University Hospital	marketed	Inactivated viral vaccine	Hepatitis A virus surface antigen
sIPV batch 1	sIPV batch 1	Institute of Medical Biology, Chinese Academy of Medical Sciences	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3
IMOVAX Polio™: Inactivated Poliomyelitis Vaccine	IMOVAX Polio™: Inactivated Poliomyelitis Vaccine	Sanofi Pasteur, a Sanofi Company	marketed	Inactivated viral vaccine
Seasonal trivalent inactivated influenza vaccine	Seasonal trivalent inactivated influenza vaccine	PATH	marketed	Inactivated viral vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 5 drugs in this class
2. Sinovac Research and Development Co., Ltd. · 2 drugs in this class
3. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
4. Federal University of Espirito Santo · 1 drug in this class
5. International Vaccine Institute · 1 drug in this class
6. MacroGenics · 1 drug in this class
7. Shandong Province Centers for Disease Control and Prevention · 1 drug in this class
8. Beijing Chaoyang District Centre for Disease Control and Prevention · 1 drug in this class
9. Zhejiang Provincial Center for Disease Control and Prevention · 1 drug in this class
10. Centers for Disease Control and Prevention · 1 drug in this class